Neurosurgery News and Research

RSS

HSV1716 clinical trial for childhood cancer receives FDA grant

A clinical trial testing a genetically reprogrammed herpes simplex virus as treatment for deadly forms of childhood cancer has received a U.S. Food and Drug Administration grant to support the research.

13 Oct 2010

Cincinnati Children's, Nationwide Children's Hospital collaborate to improve ADHD care

Doctors at Cincinnati Children's Hospital Medical Center and Nationwide Children's Hospital are collaborating to help pediatricians deliver better care to children with ADHD.

12 Oct 2010

New microchip technology to identify neuronal regenerators

Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans.

12 Oct 2010

Embryonic stem cells used in first trial for spinal cord injury

The first ever patient to receive treatment in a U.S. government approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells. He is presently being treated at the Shepherd Center in Atlanta. He was partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.

11 Oct 2010

New data on implementation of minimally invasive treatments for ruptured intracranial aneurysms

Two recent studies from the Zeenat Qureshi Stroke Research Center, in Minneapolis, MN, provide new data regarding implementation of minimally invasive treatments for ruptured intracranial aneurysms and impact on patient outcomes in U.S.

11 Oct 2010

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Integra LifeSciences Holdings Corporation announced today that it is featuring the Inforce Reinforcement Matrix at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Boston, Massachusetts.

8 Oct 2010

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Cincinnati Children's Hospital Medical Center has been named one of five national Centers of Excellence for Molecular Hematology to find new gene and cell therapies for inherited diseases affecting blood cells.

8 Oct 2010

Study suggests athletes suffer a form of injury that is difficult to diagnose

A study by researchers at Purdue University suggests that some high school football players suffer undiagnosed changes in brain function and continue playing even though they are impaired.

8 Oct 2010

Two-day symposium marks an extraordinary decade for Brown Institute for Brain Science

Just as intense concentration allows a sharp mind to perform at its peak, a research institute that concentrates pre-eminent scientists from 11 academic departments can push back the frontiers of knowledge in a complex research area: the human brain.

8 Oct 2010

Integra to present multi-center study of peripheral nerve repair at Mexico joint meeting

Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.

7 Oct 2010

Integra Total Wrist Fusion System to be featured at ASSH Annual Meeting

Integra LifeSciences Holdings Corporation announced today that it is featuring the Integra Total Wrist Fusion System at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Boston, Massachusetts.

7 Oct 2010

Vaccine improves survival of glioblastoma patients in phase II clinical trial: Researchers

A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in a phase II clinical trial, researchers at Duke University and The University of Texas MD Anderson Cancer Center reported today in the Journal of Clinical Oncology.

7 Oct 2010

Sudden cardiac arrest survivors to gather at SCAA Annual Meeting

A nationwide gathering of sudden cardiac arrest (SCA) survivors, emergency responders and civilian rescuers will mark SCA Awareness Month with a Survivors & Heroes Celebration on Friday, October 8 at 6:00 p.m. at the Marriott City Center in Pittsburgh, Pennsylvania.

7 Oct 2010

Cincinnati Children's Hospital receives $12 million grant to create IBD registry

Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.

7 Oct 2010

Synergetics anticipates $13 million net sales for fourth quarter 2010

Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and neurosurgical applications, today announced that it expects to report net sales of approximately $13 million and net income of approximately $1 million for its fourth quarter ended July 31, 2010.

6 Oct 2010

FDA clears Integra LifeSciences' Vu aPOD Prime anterior lumbar interbody fusion device

Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.

6 Oct 2010

Varian, IMRIS enter agreement to co-develop new MR-guided radiation therapy system for cancer

Varian Medical Systems, Inc., and IMRIS Inc. have concluded an agreement to co-develop an innovative new MR-guided radiation therapy system for use in treating a variety of cancers.

6 Oct 2010

ISTO announces completion of enrollment in NuQu Phase I clinical study for discogenic back pain

ISTO Technologies, Inc., an orthobiologics company with a cell-based platform for cartilage regeneration, announced today the completion of patient enrollment in the Phase I clinical study for NuQu™, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain. The study included 15 patients enrolled at two clinical sites. All patients enrolled in the trial suffered from persistent discogenic back pain and disability despite undergoing previous traditional conservative therapy.

5 Oct 2010

Researchers endeavor to create map of human brain's wiring using MEG technology

As a part of a $30 million dollar National Institutes of Health (NIH) initiative to map the human brain, Saint Louis University neurosurgeon Richard Bucholz, M.D. will image the brains of healthy adults with MEG technology, providing key information about brain function.

5 Oct 2010

Research on T cell may lead to new treatment options for type 1 diabetes

A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.

5 Oct 2010

Neurosurgery News and Research

HSV1716 clinical trial for childhood cancer receives FDA grant

Cincinnati Children's, Nationwide Children's Hospital collaborate to improve ADHD care

New microchip technology to identify neuronal regenerators

Embryonic stem cells used in first trial for spinal cord injury

New data on implementation of minimally invasive treatments for ruptured intracranial aneurysms

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Study suggests athletes suffer a form of injury that is difficult to diagnose

Two-day symposium marks an extraordinary decade for Brown Institute for Brain Science

Integra to present multi-center study of peripheral nerve repair at Mexico joint meeting

Integra Total Wrist Fusion System to be featured at ASSH Annual Meeting

Vaccine improves survival of glioblastoma patients in phase II clinical trial: Researchers

Sudden cardiac arrest survivors to gather at SCAA Annual Meeting

Cincinnati Children's Hospital receives $12 million grant to create IBD registry

Synergetics anticipates $13 million net sales for fourth quarter 2010

FDA clears Integra LifeSciences' Vu aPOD Prime anterior lumbar interbody fusion device

Varian, IMRIS enter agreement to co-develop new MR-guided radiation therapy system for cancer

ISTO announces completion of enrollment in NuQu Phase I clinical study for discogenic back pain

Researchers endeavor to create map of human brain's wiring using MEG technology

Research on T cell may lead to new treatment options for type 1 diabetes

Neuroscience - Third Edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News